The Head and Neck Cancer Drug Development Summit covers topics such as:
The mechanisms of inherent and acquired resistance
The role of the tumor in pathogenesis and treatment response
How we can tailor the treatment journey to leverage the advantages of HPV-specific immunotherapy, immune checkpoint inhibitors, chemoradiotherapy, and improve patient outcomes
Where promising avenues for targeted drug approaches for both HPV-positive and -negative subtypes are
Past Events
Head and Neck Cancer Drug Development Summit - 30 Nov - 01 Dec, 2021, Online Event (93926)
Important
Please, check "Head and Neck Cancer Drug Development Summit" official website for possible changes, before making any traveling arrangements
